Regenerx Biopharmaceuticals Inc (RGRX)

$0.00 0.00 (N/A)
Market Cap 1,000.00
Revenue (ttm) 80,000.00
Net Income (ttm) -1.73M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -2,162.50%
Debt to Equity Ratio 0.00
Volume 600
Avg Vol 2,286
Day's Range N/A - N/A
Shares Out 1.44M
Stochastic %K 0%
Beta 188.02
Analysts Strong Buy
Price Target $1.50

Company Profile

RegeneRx Biopharmaceuticals, Inc., a biopharmaceutical company, develops pharmaceuticals from Thymosin beta 4 (Tß4) for tissue protection, repair, and regeneration. The company is developing RGN-259, a sterile and preservative-free eye drop that has completed Phase 3 clinical trial for the treatment of dry eye syndrome and neurotrophic keratitis. It has strategic partnerships with Lee's Pharmaceutical Group for the development and marketing of Tß4-related products; and HLB Therapeutics for the d...

Industry: Biotechnology
Sector: Healthcare
Phone: 301 208 9191
Address:
15245 Shady Grove Road, Suite 470, Rockville, United States
dontu1dr
dontu1dr Apr. 25 at 2:07 PM
$RGRX Might want to read the following article: https://www.eyeworld.org/2026/early-momentum-in-biologics-for-corneal-conditions/ Chamberlain: ReGenTree site investigator Pflugfelder: ***NOTE*** historically has been a LONG TERM ADVOCATE for TB4 EYE -do a little research on this!!! ENJOY the read, THE DONK
0 · Reply
12e456789o
12e456789o Apr. 23 at 10:26 PM
$RGRX HLB Thera - time to head up again. Blue Minor wave 4 looks complete with a .618 retrace after the big move up. Using bar chart to show the retrace. There should be 3 more large waves up to complete the sequence.
0 · Reply
TheMotleyMonk
TheMotleyMonk Apr. 15 at 4:49 PM
$RGRX Anyone heard anything from the bunker in New Jersey? Radio silence on all fronts. Not even an update to shareholders...even a "no news" update would be appreciated.
1 · Reply
12e456789o
12e456789o Apr. 10 at 6:52 AM
$RGRX HLB Thera looking good this week
0 · Reply
12e456789o
12e456789o Mar. 31 at 9:20 PM
$RGRX 5 waves up and then a 3 wave flat. Ready for the next wave up? Daily close above 3333 and bulls are in the driver's seat.
0 · Reply
Tr5
Tr5 Mar. 24 at 10:16 PM
$RGRX HLB Therapeutics also aims to announce the top-line results of the global Phase 3 clinical trial for ' RGN-259, ' a treatment for neurotrophic keratitis ( NK ) currently under development through its subsidiary Regentry , this coming June. HLB Group Chairman Jin Yang-gon Purchases Affiliate Stocks 16 Times This Year
0 · Reply
12e456789o
12e456789o Mar. 22 at 11:52 PM
$RGRX HLB Thera. Got a monthly trend up on March 11th - Bullish. Has not yet cleared 3333 which will be the confirmation. (Not sure why data changed - it was 3500. Possibly a distribution. Not sure). The most interesting thing on the chart is that it has 5 waves up and then an overlap on the move down Friday. Normally you would think that was wave 1 completed (5 up) and now in wave 2. However the 3 waves up were all very similar in size. Often that is the give away that it is actually a 1/2-1/2-1/2 sequence, coiled and ready to explode. Let's see....Could be a great week. Staying hopeful.
0 · Reply
12e456789o
12e456789o Mar. 6 at 7:04 PM
$RGRX Friday trading had HLB Thera move up instead of down. I'm now going to favor the alternative count even though it is not confirmed yet. The bottom could be in - IMO needs a close early next week above 2910....only 30 points away! Also noticed 11k+ (Million plus pre-split) shares traded yesterday with RGRX. Time to get out the popcorn :)
1 · Reply
12e456789o
12e456789o Mar. 5 at 8:11 PM
$RGRX HLB Thera - Most likely one last wave down Friday (but could be finished)
0 · Reply
12e456789o
12e456789o Feb. 25 at 8:43 PM
$RGRX Good news/bad news. Bad news - wave 1/2 pattern broke when 2870 was penetrated a second time. Confirmed with 2770 close. Good news - It is still a flat with a 3-3-5 pattern instead of ABC-X-ABC. Here is the long term view.
1 · Reply
Latest News on RGRX
No data available.
dontu1dr
dontu1dr Apr. 25 at 2:07 PM
$RGRX Might want to read the following article: https://www.eyeworld.org/2026/early-momentum-in-biologics-for-corneal-conditions/ Chamberlain: ReGenTree site investigator Pflugfelder: ***NOTE*** historically has been a LONG TERM ADVOCATE for TB4 EYE -do a little research on this!!! ENJOY the read, THE DONK
0 · Reply
12e456789o
12e456789o Apr. 23 at 10:26 PM
$RGRX HLB Thera - time to head up again. Blue Minor wave 4 looks complete with a .618 retrace after the big move up. Using bar chart to show the retrace. There should be 3 more large waves up to complete the sequence.
0 · Reply
TheMotleyMonk
TheMotleyMonk Apr. 15 at 4:49 PM
$RGRX Anyone heard anything from the bunker in New Jersey? Radio silence on all fronts. Not even an update to shareholders...even a "no news" update would be appreciated.
1 · Reply
12e456789o
12e456789o Apr. 10 at 6:52 AM
$RGRX HLB Thera looking good this week
0 · Reply
12e456789o
12e456789o Mar. 31 at 9:20 PM
$RGRX 5 waves up and then a 3 wave flat. Ready for the next wave up? Daily close above 3333 and bulls are in the driver's seat.
0 · Reply
Tr5
Tr5 Mar. 24 at 10:16 PM
$RGRX HLB Therapeutics also aims to announce the top-line results of the global Phase 3 clinical trial for ' RGN-259, ' a treatment for neurotrophic keratitis ( NK ) currently under development through its subsidiary Regentry , this coming June. HLB Group Chairman Jin Yang-gon Purchases Affiliate Stocks 16 Times This Year
0 · Reply
12e456789o
12e456789o Mar. 22 at 11:52 PM
$RGRX HLB Thera. Got a monthly trend up on March 11th - Bullish. Has not yet cleared 3333 which will be the confirmation. (Not sure why data changed - it was 3500. Possibly a distribution. Not sure). The most interesting thing on the chart is that it has 5 waves up and then an overlap on the move down Friday. Normally you would think that was wave 1 completed (5 up) and now in wave 2. However the 3 waves up were all very similar in size. Often that is the give away that it is actually a 1/2-1/2-1/2 sequence, coiled and ready to explode. Let's see....Could be a great week. Staying hopeful.
0 · Reply
12e456789o
12e456789o Mar. 6 at 7:04 PM
$RGRX Friday trading had HLB Thera move up instead of down. I'm now going to favor the alternative count even though it is not confirmed yet. The bottom could be in - IMO needs a close early next week above 2910....only 30 points away! Also noticed 11k+ (Million plus pre-split) shares traded yesterday with RGRX. Time to get out the popcorn :)
1 · Reply
12e456789o
12e456789o Mar. 5 at 8:11 PM
$RGRX HLB Thera - Most likely one last wave down Friday (but could be finished)
0 · Reply
12e456789o
12e456789o Feb. 25 at 8:43 PM
$RGRX Good news/bad news. Bad news - wave 1/2 pattern broke when 2870 was penetrated a second time. Confirmed with 2770 close. Good news - It is still a flat with a 3-3-5 pattern instead of ABC-X-ABC. Here is the long term view.
1 · Reply
12e456789o
12e456789o Feb. 13 at 9:04 PM
$RGRX This week saw two more waves put in with a net loss of 10pts. This last wave is a 5 wave structure just like the first wave down so this has to be a simple ABC zigzag with the irregular wave labeled as B instead of X. "Monitor and adjust" Still think this is waves 1 and 2 of the new bull but IMO the chart is at max tension and cannot accommodate any more waves down.
1 · Reply
12e456789o
12e456789o Feb. 6 at 6:02 PM
$RGRX The corrective wave 2 morphed into a double zigzag (WXY) or abc-X-abc. Using a bar chart to show the first move down is actually a diagonal. This is allowed with Elliott Wave. Then you have the irregular X wave. Final wave down is a simple 3 wave structure and the last leg of it creates a positive divergence with the daily RSI 5 (bottom of the chart). Confirmation will be a move to close above the ema 13 which is currently at 3085. With a move up next week we will finally be in wave 3 and it should start moving explosively soon. Close below 2770 invalidates this count.
0 · Reply
12e456789o
12e456789o Jan. 30 at 7:37 AM
$RGRX HLB Thera - Chart from last week had Jan 21st low as either wave 2 or A. Ended up being the A wave of an irregular flat. Wave 2 is complete now.
0 · Reply
12e456789o
12e456789o Jan. 22 at 9:10 PM
$RGRX HLB Thera - 5 up off the low to create wave 1. Wave 2 now likely complete. Wave 3 targets 4200 area (minimum)
0 · Reply
12e456789o
12e456789o Dec. 23 at 10:54 PM
$RGRX HLB Thera got a 2770 close on 12/18 so the multi year flat is complete. Looking for a positive divergence with the daily RSI 5 so most likely there will be one more mini swoon down to 2770 or a little lower in the next few days before the bottom is complete. 2026 looking inviting.
0 · Reply
dontu1dr
dontu1dr Nov. 27 at 10:31 PM
$RGRX Maybe Regenerx should consider partnering up with HLB in some form or another as HLB looks like they are good at getting things accomplished in the biotech industry? They seem to be a biotech on the move. THE DONKER
0 · Reply
dontu1dr
dontu1dr Nov. 26 at 1:30 PM
$RGRX if you go to the US CLINICAL TRIAL #: NCT05555589 and look at the changes that were made on: 10/21/25 (you can do this on the "record history tab" folks) Regentree made the following changes in OCTOBER 2025 Primary Completion 2025-12-31 [Estimated] Study Completion 2026-02-28 [Estimated] ASK yourself why they would be that accurate in the short term? that's a bit of a TELL, folks... It looks like they are "understating" their progress a bit to the public and being a bit more "accurate" in the clinical trial info in both the US & EUROPE. But that kinda "par for the course in biotech" at this point in the adventure... THE DONKER
1 · Reply
dontu1dr
dontu1dr Nov. 23 at 7:10 PM
$RGRX NOTE*** THIS IS RELEVANT: https://dealsite.co.kr/articles/151910 SUMMED up: HLB Therapeutics Co.,Ltd. announced a private placement to issue 1% Series 20 Unregistered Unsecured Private Convertible Bonds due December 4, 2028 for gross proceeds of KRW 17,000,000,000 on November 20, 2025. The company said, "The funds raised will be used for clinical trials of NK treatment and operating funds." -sometimes in PHARMA, they'll do a PIPE two or three months before a deal of some sort... -things could get interesting, maybe sooner than later. THE DONKER
0 · Reply
dontu1dr
dontu1dr Nov. 20 at 1:02 PM
$RGRX Read the following article: HLB Therapeutics Secures European Patent for RGN-259 Manufacturing Process, Announces IP System PATENTS are "life blood" of BIOPHARMA POINTS OF INTEREST: -Currently, HLB Therapeutics is proceeding smoothly with its Phase 3 clinical trial (SEER-2) for a neurotrophic keratitis (NK) treatment, centered on clinical sites in the United States. Furthermore, at last month's American Academy of Ophthalmology (AAO) Annual Meeting in Orlando, Florida, HLB Therapeutics met with key partners and confirmed their continued interest. -"In addition to the anticipation for the SEER-2 clinical trial, which has already progressed considerably, securing patents related to the RGN-259 manufacturing process in major countries is significant in that it gives us important intellectual property (IP) that will further strengthen our position in future negotiations with global big pharma companies." https://www.news1.kr/bio/pharmaceutical-bio/5978540
1 · Reply
dontu1dr
dontu1dr Nov. 13 at 3:53 PM
$RGRX 2nd TB4 EU Trial #: (do a search on it) 2024-518969-98-00 Medical condition(s)Neurotrophic Keratopathy Trial PhaseTherapeutic confirmatory (Phase III) Trial Duration: Start of trial 04/11/2025 Estimated end of trial date in EU/EEA: 25/11/2025 or November 25, 2025 Estimated global end date of the trial: 25/11/2025 or November 25, 2025 At this point in time, looks like ITALY is the only point recruiting vs SPAIN & POLAND, which might infer they’re keeping a “tighter control” on this Euro Trial. The Donker
0 · Reply
12e456789o
12e456789o Nov. 6 at 7:45 PM
$RGRX Here's what I am seeing for HLB Thera. The entire correction after 2018 high is double zigazag or abc-x-abc. Chart is currently finishing the last c wave which is a 5 wave sequence. Monday's high cemented the 3rd wave bottom. 4th wave could now be completed or could continue up a little further. Either way there should be one more wave down that will take the price below 2780 to finish a multi year flat.
0 · Reply
dontu1dr
dontu1dr Oct. 22 at 12:18 PM
$RGRX It will be interesting to read fda's "fda plausible mechanism pathway" to be published in a week or two in the New England Journal, won't it? This would/could negate the NK Euro Trial results being needed. And when you consider "dompe's oxervate" price, complexity of using for seniors, side effects, ect--- Humanitarian decision would make sense/cents. Also, take in consideration RFK Jr's interest in peptides... Just because most folks don't follow such things, doesn't mean BIG PHARMA is ignorant about what is happening behind the scenes. ALSO, don't forget about Wayne States world patent app: https://patents.google.com/patent/WO2024233903A1/en?oq=WO%2f2024%2f233903 A real break-thru for diabetic eye problems... read that patent app if you have time... All this makes sense/cents doesn't it? THE DONKER
1 · Reply